Peptide knowledge center
Peptides and Research Materials Guide
Peptides are short chains of amino acids joined by peptide bonds. The field covers many molecules, analytical methods, and research questions, so it is important to distinguish a scientific name, a search abbreviation, a research material, and an approved medicine.
What is a peptide?
A peptide is an amino-acid sequence. Biochemistry references commonly describe peptides as relatively short chains, while proteins are generally larger and structurally more complex. Length is not the whole definition: sequence, conformation, chemical modifications, and analytical method all affect how a molecule is studied.
The JEWJITSU PEPTIDES catalog organizes peptides and research materials by name, strength, and package quantity. A catalog listing does not establish medical approval, human suitability, or a treatment outcome. Regulatory information should be checked against the official source for the specific approved drug product.
RETA: a search shorthand for Retatrutide
RETA is a common search shorthand for Retatrutide. The formal name matters. ClinicalTrials.gov records identify the molecule as LY3437943 and list Phase 3 studies; registration of a clinical trial is not marketing approval and is not a recommendation for use.
The catalog page provides catalog specifications only. Readers looking for scientific evidence should continue to the registry record or a peer-reviewed publication and examine the population, design, results, and current study status.
TESA, PEPS, and GLP3: search terms versus formal names
TESA is sometimes used as shorthand for Tesamorelin. It refers to a defined molecule, but the indication of an approved drug product is determined by that product's FDA label. The EGRIFTA label specifically distinguishes its approved indication from weight-loss management.
PEPS is an ambiguous search abbreviation rather than a standard scientific name; this site directs it to the complete term peptides. GLP3 is also not an official drug class or a catalog product name. It is sometimes used imprecisely when searchers mean triple-agonist research involving GLP‑1, GIP, and glucagon pathways. We use the formal terms to avoid confusion.
How to read research-material information
Start with the full name and spelling, then check the source type, update date, study population, and whether results have been posted. A trial registry describes what is planned or studied; a paper describes methods and findings; a regulatory label defines an approved drug product and its indications.
A useful search does not end at a product name. Laboratory data, animal research, clinical trials, and regulatory information represent different levels of evidence. The site's news pages link directly to original sources so readers can make that distinction themselves.